Hemolytic Anemia Complicating COVID-19 Infection

Abeer N AbouYabis; Grace Thompson Bell

doi:10.14740/jh906

Hemolytic Anemia Complicating COVID-19 Infection

J Hematol. 2021 Oct;10(5):221-227. doi: 10.14740/jh906. Epub 2021 Oct 5.

Authors

Abeer N AbouYabis¹, Grace Thompson Bell¹

Affiliation

¹ Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.

PMID: 34804312
PMCID: PMC8577589
DOI: 10.14740/jh906

Abstract

Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy. Moreover, there have been documented cases of hemolytic anemia associated with COVID-19 infection which have been mainly attributed to development of autoantibodies. We report a case of an African-American patient who presented with hemolytic anemia in the second week after his COVID-19 diagnosis. Throughout this report, we explore the potential immune and non-immune etiologies that contributed to the patient's hemolytic anemia in the setting of COVID-19 infection guided by a review of literature.

Keywords: Autoimmune hemolytic anemia; COVID-19; G6PD deficiency; Hemolytic anemia.

Publication types

Case Reports